Cell-Based Assays: Technologies and Global Markets

Aug 2022| BIO080E| BCC Publishing
Sample Report

Report Highlights

The global cell-based assays market should reach $47.3 billion by 2027 from $29.2 billion in 2022 at a compound annual growth rate (CAGR) of 10.2% for the forecast period of 2022 to 2027.

Report Includes

  • 63 tables
  • An up-to-date review of the global markets for cell-based assays and related technologies
  • Analyses of the global market trends, with historic sales data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future potential in the market for cell-based assays, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size for cell-based assays, revenue forecast, and corresponding market share analysis based on product, type/application, end user and geographic region
  • Market assessment of the cell-based assays available and currently being used, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
  • Coverage of major issues involved in the research and development (R&D) of more effective cell-based approaches for drug discovery
  • In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
  • Competitive analysis of the market for cell-based assays and updated information on the mergers, acquisitions, collaborations and recent developments during the 2020-2022 period
  • Descriptive company profiles of the leading global players, including Becton, Dickinson & Company, Charles River Laboratories, General Electric Healthcare, Merck KGaA and Thermo Fisher Scientific Inc.

Report Scope

This report is an update of an earlier report of the same title. This report offers a comprehensive analysis of the global cell-based assays market. Segmentation is based on product, type/application and end user. Based on type/application, the market is segmented as drug discovery for validating drug targets/lead profiling assays, absorption, distribution, metabolism, and excretion (ADME) toxicity assays and basic research. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The report provides a detailed overview and analysis of the present and future global market for cell-based assay techniques. The report analyzes in detail currently available cell-based assays and their markets. Industry growth drivers, restraints and opportunities are also discussed in detail. The report also provides information on competitive landscape, elaborative company profiles and the impact of COVID-19 on the market.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022–2027
Base year market size $26.5 billion
Market size forecast $47.3 billion
Growth rate CAGR of 10.2% from 2022 to 2027
Units considered $ Millions
Segments covered Application, Segment, End User, Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Rest of Asia-Pacific, U.S., Canada
Key Market Drivers
  • Increasing Incidence of Chronic Diseases
  • Demand for Personalized Medicine
  • Demand for Effective Drug Discovery and Development Process
  • Increasing Investments for Drug Research and Development
  • Technological Developments
Companies studied
AGILENT TECHNOLOGIES INC.
BECTON, DICKINSON & CO.
BIOIVT
BIO-RAD LABORATORIES
CELL BIOLOGICS
CELL BIOLABS INC.
CELL SIGNALING TECHNOLOGY INC.
CHARLES RIVER
CORNING, INC.
DANAHER
DISCOVERX CORP.
ENZO LIFE SCIENCES
EVOTEC AG
FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
GE HEALTHCARE
LONZA
MERCK KGAA
ONCOLMMUNIN
PERKINELMER
PROMEGA CORP.
THERMO FISHER SCIENTIFIC

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Cell-Based Assays: Technologies and Global Markets234 $5,500 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Overview53$1,246Free
Chapter- 4: Assays for Drug Discovery22$517Free
Chapter- 5: Cell-Based Assays: Current Technologies34$799Free
Chapter- 6: Commercialization of Cell-Based Assays12$282Free
Chapter- 7: Market Dynamics7$165Free
Chapter- 8: Impact of COVID-194$94Free
Chapter- 9: Global Market for Cell-Based Assays by Application13$306Free
Chapter- 10: Global Market for Cell-Based Assays by Segment9$212Free
Chapter- 11: Cell-Based Assays Market by End User8$188Free
Chapter- 12: Global Market for Cell-Based Assays by Region23$541Free
Chapter- 13: Competitive Landscape3$71Free
Chapter- 14: Company Profiles37$870Free
Published - Dec-2018| Analyst - Sathya Durga| Code - BIO080D

Report Highlights

The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.

Report Includes

  • 23 data tables and 48 additional tables
  • Detailed overview of the global market for cell-based assays within the industry
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Details of important assays, technologies and the latest developments and outlines market shares by assay type and company, with a special emphasis on the U.S. market
  • Regional dynamics of cell-based assays covering North America, Europe and other emerging economies
  • Examination of the cell-based assays available and currently being used, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
  • Discussion of current issues and trends affecting the industry, as well as costs and factors that have an impact on demand
  • Coverage of major issues involved in the research and development (R&D) of more effective cell-based approaches for drug discovery
  • Company profiles of major players in the industry including Beckman Coulter, DiscoverX, PerkinElmer, Life Technologies and Promega Corp.
Published - Jul-2017| Analyst - Usha Nagavarapu| Code - BIO080C

Report Highlights

The global market for cell-based assays reached $15.2 billion in 2015. This market is expected to increase from $17.1 billion in 2016 to nearly $28.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.6% for 2016-2021.

Report Includes

  • An overview of the global markets and related technologies for cell-based assays.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.
  • The current market status of cell-based assays in terms of strengths, weaknesses, opportunities and threats facing various assays and developments already on the market.
  • Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand.
  • Coverage of new technologies, trends, alliances, and mergers.
  • Profiles of major players in the industry.
Published - Apr-2014| Analyst - Usha Nagavarapu| Code - BIO080B

Report Highlights

BCC Research estimates that the global market for cell-based assays will increase at a compound annual growth rate (CAGR) of 12.4% over the next five years to reach $15.2 billion in 2015 and $21.6 billion by 2018 from $12.1 billion in 2013.

Report Includes

  • An overview of the global market for cell-based assays available and currently used.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery, and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.
  • Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand.
  • Coverage of new technologies, trends, alliances, and mergers.
Published - May-2011| Analyst - Usha Nagavarapu| Code - BIO080A

Report Highlights

Cell biology is currently the biggest revenue contributor to the life-science tools industry, accounting for approximately 30% of total sales.  It is expected to grow to a $15 billion market by 2015, increasing at a compound annual growth rate (CAGR) of 12.3% from its 2010 value of $8.5 billion.

Cell-Based Assays: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS